Compass Pathways Plc ADR (CMPS)

$6.29 -0.14 (-2.18%)
Market Cap 616.90M
Revenue (ttm) 0.00
Net Income (ttm) -155.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.19
Volume 2,189,200
Avg Vol 1,791,488
Day's Range N/A - N/A
Shares Out 95.94M
Stochastic %K 78%
Beta 2.21
Analysts Strong Sell
Price Target $14.90

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
McGuireTO
McGuireTO Oct. 7 at 1:59 AM
$ATAI $MNMD $CMPS $PSIL Sorry it's been so long since my last update, as explained in this video - Travel in the Caribbean, Stomach flu, and surgery on my nose kept me unable to record an update. But here it is, detailing what we're looking for into tomorrow and the rest of the week!
2 · Reply
McGuireTO
McGuireTO Oct. 7 at 1:13 AM
$ATAI $MNMD $CMPS $PSIL Click here to watch the free video! Where do we stand in the psychedelic sector now that ATAI's BPL-009 Phase 3a readout broke out to higher highs, and CMPS and MNMD finally broke through their resistances? Are we anticipating continuation? What about CYBN? I cover it all in this video. I post regular technical analysis of the psychedelic sector, be sure to Like this post and follow me to stay on top of things and not miss an update! https://www.tradingview.com/chart/CYBN/XInp84lQ-Psychedelic-Sector-Update-Oct-6th/
1 · Reply
SlayQueenOfCalls
SlayQueenOfCalls Oct. 6 at 6:12 PM
$CMPS thank you. I’m out for now.. love the stock hate the options 🥱🥱
1 · Reply
PsychedStocks
PsychedStocks Oct. 6 at 3:44 PM
$CYBN $CMPS $MNMD $ATAI $PFE
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 4:45 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.43 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $2.52- $3.08 Scale out: $3.92-$5.04 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
PsychedStocks
PsychedStocks Oct. 4 at 3:34 PM
$CYBN $CMPS $ATAI $MNMD
1 · Reply
cacci11
cacci11 Oct. 4 at 2:48 AM
$CMPS so…no news?
0 · Reply
zmanx
zmanx Oct. 3 at 9:22 PM
$CMPS solid start to q4 here as it breaks out of this falling wedge. Good job if you decided to keep holding after the flat data reaction
2 · Reply
FBP
FBP Oct. 3 at 8:04 PM
$CMPS wow quite the day!
0 · Reply
BeforeTheRobots
BeforeTheRobots Oct. 3 at 8:03 PM
$CMPS quite the close
0 · Reply
Latest News on CMPS
COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 2:03 PM EDT - 27 days ago

COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 4:56 AM EDT - 4 weeks ago

COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Sep 2, 2025, 6:30 AM EDT - 5 weeks ago

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Compass Pathways to Participate in Four Investor Conferences in September

Aug 27, 2025, 6:30 AM EDT - 5 weeks ago

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Aug 5, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 10:32 AM EDT - 2 months ago

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 31, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 29, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Appoints Justin Gover to Board of Directors

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 22, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jul 10, 2025, 4:00 PM EDT - 3 months ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 24, 2025, 2:47 PM EDT - 3 months ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jun 23, 2025, 8:25 AM EDT - 3 months ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 8:12 AM EDT - 3 months ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 3 months ago

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Jun 23, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:14 AM EDT - 5 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 29, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 28, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Apr 22, 2025, 6:00 AM EDT - 6 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 6 months ago

This Is a Test From GlobeNewswire

ALVO

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 26, 2025, 6:30 AM EDT - 6 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in Stifel Virtual CNS Forum

Mar 11, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 28, 2025, 5:08 PM EST - 7 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 4:02 PM EST - 7 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:41 AM EST - 7 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 27, 2025, 6:30 AM EST - 7 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 4:00 PM EST - 7 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 18, 2025, 6:30 AM EST - 8 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 6:30 AM EST - 8 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 21, 2025, 6:30 AM EST - 9 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025, 7:01 AM EST - 9 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Dec 18, 2024, 6:30 AM EST - 10 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Compass Pathways to Participate in December Investor Conferences

Nov 25, 2024, 4:00 PM EST - 11 months ago

Compass Pathways to Participate in December Investor Conferences

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 14, 2024, 7:44 AM EST - 11 months ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Top 3 Health Care Stocks You'll Regret Missing In November

Nov 5, 2024, 6:58 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 1, 2024, 5:10 PM EDT - 1 year ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 2:49 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 31, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Oct 24, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Sep 23, 2024, 7:00 AM EDT - 1 year ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Compass Pathways to participate in three investor conferences in September

Aug 28, 2024, 6:00 AM EDT - 1 year ago

Compass Pathways to participate in three investor conferences in September

Psychedelic Stocks: Focus On Their Cash

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 4, 2024, 1:22 AM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Compass Pathways announces second quarter 2024 financial results and business highlights

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

McGuireTO
McGuireTO Oct. 7 at 1:59 AM
$ATAI $MNMD $CMPS $PSIL Sorry it's been so long since my last update, as explained in this video - Travel in the Caribbean, Stomach flu, and surgery on my nose kept me unable to record an update. But here it is, detailing what we're looking for into tomorrow and the rest of the week!
2 · Reply
McGuireTO
McGuireTO Oct. 7 at 1:13 AM
$ATAI $MNMD $CMPS $PSIL Click here to watch the free video! Where do we stand in the psychedelic sector now that ATAI's BPL-009 Phase 3a readout broke out to higher highs, and CMPS and MNMD finally broke through their resistances? Are we anticipating continuation? What about CYBN? I cover it all in this video. I post regular technical analysis of the psychedelic sector, be sure to Like this post and follow me to stay on top of things and not miss an update! https://www.tradingview.com/chart/CYBN/XInp84lQ-Psychedelic-Sector-Update-Oct-6th/
1 · Reply
SlayQueenOfCalls
SlayQueenOfCalls Oct. 6 at 6:12 PM
$CMPS thank you. I’m out for now.. love the stock hate the options 🥱🥱
1 · Reply
PsychedStocks
PsychedStocks Oct. 6 at 3:44 PM
$CYBN $CMPS $MNMD $ATAI $PFE
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 4:45 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.43 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $2.52- $3.08 Scale out: $3.92-$5.04 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
PsychedStocks
PsychedStocks Oct. 4 at 3:34 PM
$CYBN $CMPS $ATAI $MNMD
1 · Reply
cacci11
cacci11 Oct. 4 at 2:48 AM
$CMPS so…no news?
0 · Reply
zmanx
zmanx Oct. 3 at 9:22 PM
$CMPS solid start to q4 here as it breaks out of this falling wedge. Good job if you decided to keep holding after the flat data reaction
2 · Reply
FBP
FBP Oct. 3 at 8:04 PM
$CMPS wow quite the day!
0 · Reply
BeforeTheRobots
BeforeTheRobots Oct. 3 at 8:03 PM
$CMPS quite the close
0 · Reply
ClownThePoet
ClownThePoet Oct. 3 at 6:21 PM
$ATAI red $CMPS green. good shit
0 · Reply
Stoneape
Stoneape Oct. 3 at 1:55 PM
$CMPS this and $TLRY by far my best performers. I do expect this to keep going. Will sell half my position in both once double up is confirmed. Ride on free shares!
1 · Reply
BobJohnBuoy666
BobJohnBuoy666 Oct. 3 at 1:46 PM
$CMPS weekly looks sexy AF
0 · Reply
Jebuliz
Jebuliz Oct. 3 at 1:37 PM
$CMPS 7$ today
1 · Reply
DriuxP
DriuxP Oct. 2 at 8:03 PM
$CMPS beautiful way to close the day
0 · Reply
ClownThePoet
ClownThePoet Oct. 2 at 8:03 PM
$CMPS proud of u compass $ATAI
0 · Reply
ClownThePoet
ClownThePoet Oct. 2 at 8:03 PM
$CMPS THIS IS HUGE!! GLAD I ALL IN’D THIS. TIME WILL TELL!
0 · Reply
Ramirami43
Ramirami43 Oct. 2 at 7:53 PM
$ATAI stuck here or following $CMPS soon?
1 · Reply
BankOnTheFuture
BankOnTheFuture Oct. 2 at 6:37 PM
$CMPS Really nice fill of the gap of $5.50 to $6.25 underway the last week. Then clear skies up to $9.00!
0 · Reply
ClownThePoet
ClownThePoet Oct. 2 at 1:51 PM
$CMPS SEND THIS TO 6$!!! $SPY
2 · Reply
TalkMarkets
TalkMarkets Oct. 1 at 10:46 PM
Top 4 "Psych" Stocks Went Crazy In September Going Up +18% - Here's Why $ATAI $MNMD $CMPS $GHRS https://talkmarkets.com/content/stocks--equities/top-4-psych-stocks-went-crazy-in-september-going-up-18-heres-why?post=525544
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Oct. 1 at 8:59 PM
$CMPS $MNMD over 100 million more cash. Less debt. Stonger data so far and easier to protect IP since it’s not a mushroom.
2 · Reply